Angiogenic markers and maternal echocardiographic indices in women with hypertensive disorders of pregnancy.

PlGF angiogenic markers cardiovascular echocardiography hypertensive disorders of pregnancy preeclampsia sFlt-1

Journal

Ultrasound in obstetrics & gynecology : the official journal of the International Society of Ultrasound in Obstetrics and Gynecology
ISSN: 1469-0705
Titre abrégé: Ultrasound Obstet Gynecol
Pays: England
ID NLM: 9108340

Informations de publication

Date de publication:
07 Sep 2023
Historique:
revised: 11 08 2023
received: 23 05 2023
accepted: 24 08 2023
medline: 7 9 2023
pubmed: 7 9 2023
entrez: 7 9 2023
Statut: aheadofprint

Résumé

The maternal cardiovascular system of women with hypertensive disorders of pregnancy (HDP) can be impaired, with higher rates of left ventricular (LV) remodelling and diastolic dysfunction compared to normotensive pregnancies. The primary objective of this prospective study was to correlate cardiac indices obtained by transthoracic echocardiography (TTE) and circulating angiogenic markers, such as soluble fms-like tyrosine kinase 1 (sFlt-1) and placental growth factor (PlGF). 95 women with a pregnancy complicated by HDP and a group of 25 uncomplicated pregnancies at term underwent TTE and blood tests to measure sFlt-1 and PLGF during the peripartum period (before delivery and within a week of giving birth). Spearman's rank correlation was used to report correlation coefficients between biomarkers and cardiac indices in the HDP population and controls. HDP group included 61 (64.2%) preeclamptic patients and, among them, 42 (68.9%) delivered before 37 weeks. 12 HDP out of 95 (12.6%) patients underwent blood samples and TTE after delivery, and, as they showed significantly lower levels of angiogenic markers, they were excluded from the analysis. There was a correlation between sFlt-1 and LVMI (r=0.246, p=0.026) and E/e' (r=0.272, p=0.014) in HDP (n=83), while in controls sFlt-1 showed a correlation with RWT (r=0.409, p=0.043), lateral e' (r=-0.562, p=0.004) and E/e' (r=0.417, p=0.042). PlGF correlated with LVMI (r=-0.238, p=0.031) in HDP patients and with lateral e' (r=0.466, p=0.022) in controls. sFlt-1/PlGF ratio correlated with lateral e' (r=-0.568, p=0.004) and E/e' (r=0.428, p=0.037) in controls and with LVMI (r=0.252, p=0.022) and E/e' (r=0.269, p=0.014) in HDP. Although the current data are not able to infer causality, they confirm the intimate relationship between the maternal cardiovascular system and endothelial markers that are used both to diagnose and indicate the severity of HDP. This article is protected by copyright. All rights reserved.

Identifiants

pubmed: 37675647
doi: 10.1002/uog.27474
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Informations de copyright

This article is protected by copyright. All rights reserved.

Auteurs

V Giorgione (V)

Vascular Biology Research Center, Molecular and Clinical Sciences Research Institute, St George's University of London, London, UK.
Fetal Medicine Unit, St George's University Hospitals NHS Foundation Trust, London, UK.

C Di Fabrizio (C)

Vascular Biology Research Center, Molecular and Clinical Sciences Research Institute, St George's University of London, London, UK.
Systems Medicine, School of Medicine, University of Dundee, Dundee, UK.

E Giallongo (E)

Intensive Care National Audit & Research Centre, London, UK.

A Khalil (A)

Vascular Biology Research Center, Molecular and Clinical Sciences Research Institute, St George's University of London, London, UK.
Fetal Medicine Unit, St George's University Hospitals NHS Foundation Trust, London, UK.

J O'Driscoll (J)

Department of Cardiology, St George's University Hospitals NHS Foundation Trust, London, United Kingdom.
School of Psychology and Life Sciences, Canterbury Christ Church University, Kent, United Kingdom.

G Whitley (G)

Vascular Biology Research Center, Molecular and Clinical Sciences Research Institute, St George's University of London, London, UK.

G Kennedy (G)

Immunoassay Biomarker Core Laboratory, School of Medicine, University of Dundee.

C E Murdoch (CE)

Systems Medicine, School of Medicine, University of Dundee, Dundee, UK.

B Thilaganathan (B)

Vascular Biology Research Center, Molecular and Clinical Sciences Research Institute, St George's University of London, London, UK.
Fetal Medicine Unit, St George's University Hospitals NHS Foundation Trust, London, UK.

Classifications MeSH